LGALS3BP and glioblastoma: Although our results show a significant increase of vesicular‐associated LGALS3BP expression in GBM patients as compared to healthy controls, further studies in a larger series of patients are required to validate EVs‐associated LGALS3BP as a potential circulating marker for GBM.